Valerie de Haas (Valérie de Haas)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 17

Top Topics

Acute Myeloid Leukemia

Aortic Dissection

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Inge M Van der Sluis, Leiah J Brigitha, Marta Fiocco, Hester A de Groot-Kruseman, Marc Bierings, Cor van den Bos, Valerie de Haas, Peter M Hoogerbrugge, Wim J E Tissing, Margreet A Veening, Rob Pieters
Continuous PEGasparaginase Dosing Reduces Hypersensitivity Reactions in Pediatric ALL: A Dutch Childhood Oncology Group ALL11 Randomized Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Janine Stutterheim, Rachella van der Waarden, Hester A de Groot-Kruseman, Edwin Sonneveld, Valerie de Haas, Rana Dandis, C Ellen van der Schoot, Vincent H J van der Velden, Rob Pieters
Are measurable residual disease results after consolidation therapy useful in children with acute lymphoblastic leukemia? Leukemia (2024)
Inge M Van der Sluis, Leiah J Brigitha, Marta Fiocco, Hester A de Groot-Kruseman, Marc Bierings, Cor van den Bos, Valerie de Haas, Peter M Hoogerbrugge, Wim J E Tissing, Margreet A Veening, Rob Pieters
Continuous PEGasparaginase Dosing Reduces Hypersensitivity Reactions in Pediatric ALL: A Dutch Childhood Oncology Group ALL11 Randomized Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Anthony V Moorman, Amir Enshaei, Daniel Murdy, Melvin Joy, Judith M Boer, Monique L Den Boer, Rob Pieters, Valerie de Haas, Martin A Horstmann, Gabriele Escherich, Bertil Johansson, Hanne Vibeke Hansen Marquart, Kjeld Schmiegelow, Jeremy Hancock, John P Moppett, Mats Heyman
Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction. Leukemia (2024)
Inge M Van der Sluis, Leiah J Brigitha, Marta Fiocco, Hester A de Groot-Kruseman, Marc Bierings, Cor van den Bos, Valerie de Haas, Peter M Hoogerbrugge, Wim J E Tissing, Margreet A Veening, Rob Pieters
Continuous PEGasparaginase Dosing Reduces Hypersensitivity Reactions in Pediatric ALL: A Dutch Childhood Oncology Group ALL11 Randomized Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Anthony V Moorman, Amir Enshaei, Daniel Murdy, Melvin Joy, Judith M Boer, Monique L Den Boer, Rob Pieters, Valerie de Haas, Martin A Horstmann, Gabriele Escherich, Bertil Johansson, Hanne Vibeke Hansen Marquart, Kjeld Schmiegelow, Jeremy Hancock, John P Moppett, Mats Heyman
Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction. Leukemia 38 (9) (2024)
Inge M Van der Sluis, Leiah J Brigitha, Marta Fiocco, Hester A de Groot-Kruseman, Marc Bierings, Cor van den Bos, Valerie de Haas, Peter M Hoogerbrugge, Wim J E Tissing, Margreet A Veening, Rob Pieters
Continuous PEGasparaginase Dosing Reduces Hypersensitivity Reactions in Pediatric ALL: A Dutch Childhood Oncology Group ALL11 Randomized Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Inge M Van der Sluis, Leiah J Brigitha, Marta Fiocco, Hester A de Groot-Kruseman, Marc Bierings, Cor van den Bos, Valerie de Haas, Peter M Hoogerbrugge, Wim J E Tissing, Margreet A Veening, Rob Pieters
Continuous PEGasparaginase Dosing Reduces Hypersensitivity Reactions in Pediatric ALL: A Dutch Childhood Oncology Group ALL11 Randomized Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Anthony V Moorman, Amir Enshaei, Daniel Murdy, Melvin Joy, Judith M Boer, Monique L Den Boer, Rob Pieters, Valerie de Haas, Martin A Horstmann, Gabriele Escherich, Bertil Johansson, Hanne Vibeke Hansen Marquart, Kjeld Schmiegelow, Jeremy Hancock, John P Moppett, Mats Heyman
Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction. Leukemia 38 (9) (2024)
Anthony V Moorman, Amir Enshaei, Daniel Murdy, Melvin Joy, Judith M Boer, Monique L Den Boer, Rob Pieters, Valerie de Haas, Martin A Horstmann, Gabriele Escherich, Bertil Johansson, Hanne Vibeke Hansen Marquart, Kjeld Schmiegelow, Jeremy Hancock, John P Moppett, Mats Heyman
Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction. Leukemia 38 (9) (2024)
Rob Pieters, Hester de Groot-Kruseman, Marta Fiocco, Femke Verwer, Merian Van Overveld, Edwin Sonneveld, Vincent H J van der Velden, H Berna Beverloo, Marc Bierings, Natasja Dors, Valerie de Haas, Peter M Hoogerbrugge, Inge M Van der Sluis, Wim Tissing, Margreet A Veening, Judith M Boer, Monique Den Boer
Improved Outcome for ALL by Prolonging Therapy for IKZF1 Deletion and Decreasing Therapy for Other Risk Groups. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Emilia J Kozyra, Gudrun Göhring, Dennis D Hickstein, Katherine R Calvo, Courtney D D DiNardo, Michael Dworzak, Valerie de Haas, Jan Starý, Henrik Hasle, Akiko Shimamura, Mark Daniel Fleming, Hiroto Inaba, Sara Lewis, Amy P Hsu, Steven M Holland, Danielle E Arnold, Cristina Mecucci, Siobán B Keel, Alison A Bertuch, Kiran Tawana, Shlomit Barzilai, Shinsuke Hirabayashi, Masahiro Onozawa, Shaohua Lei, Helena Alaiz, Hajnalka Andrikovics, David Betts, Berna H Beverloo, Jochen Buechner, Martin Čermák, José Cervera, Olga Haus, Kirsi Jahnukainen, Kalliopi N Manola, Karin Nebral, Francesco Pasquali, Joelle Tchinda, Dominik Turkiewicz, Nadine Van Roy, Zuzana Zemanova, Victor B Pastor, Brigitte Strahm, Peter Noellke, Charlotte M Niemeyer, Brigitte Schlegelberger, Ayami Yoshimi, Marcin W Wlodarski
Association of unbalanced translocation der(1;7) with germline GATA2 mutations. Blood 138 (23) (2022)
Jayne Y Hehir-Kwa, Marco J Koudijs, Eugene T P Verwiel, Lennart A Kester, Marc van Tuil, Eric Strengman, Arjan Buijs, Mariëtte E G Kranendonk, Laura S Hiemcke-Jiwa, Valerie de Haas, Ellen van de Geer, Wendy de Leng, Jasper van der Lugt, Philip Lijnzaad, Frank C P Holstege, Patrick Kemmeren, Bastiaan B J Tops
Improved Gene Fusion Detection in Childhood Cancer Diagnostics Using RNA Sequencing. JCO precision oncology 6 (2022)
Anita W Rijneveld, Bronno van der Holt, Okke de Weerdt, Bart J Biemond, Arjan A Van de Loosdrecht, Lotte E van der Wagen, Mar Bellido, Michel van Gelder, Walter J F M van der Velden, Dominik Selleslag, Daniëlle van Lammeren-Venema, Constantijn Jm Jm Halkes, Rob Fijnheer, Violaine Havelange, Geerte van Sluis, Marie-Cecile J C Legdeur, Dries H Deeren, Alain Pa Gadisseur, Harm A M Sinnige, Dimitri Breems, Aurélie Jaspers, Ollivier Legrand, Wim E Terpstra, Rinske Boersma, Dominiek Mazure, Agnes Triffet, Lidwine Tick, Karolien Anne Beel, Johan A Maertens, H Berna Beverloo, Marleen H Bakkus, Christa Homburg, Valerie de Haas, Vincent H J van der Velden, Jan J Cornelissen
Clofarabine added to intensive treatment in adult patients with newly diagnosed ALL: the HOVON-100 trial. Blood advances (2021)
Annelien L van Binsbergen, Valerie de Haas, Vincent H J van der Velden, Hester A de Groot-Kruseman, Marta F Fiocco, Rob Pieters
Efficacy and toxicity of high-risk therapy of the Dutch Childhood Oncology Group in childhood acute lymphoblastic leukemia. Pediatric blood & cancer (2021)
Bianca Frederika Goemans, Sanne Noort, Marjolein Blink, Yong-Dong Wang, Susan T C J Peters, Jacobus P van Wouwe, Gertjan Kaspers, Valerie de Haas, Wouter J Kollen, Vincent H J van der Velden, Tanja A Gruber, Christian M Zwaan
Sensitive GATA1 mutation screening reliably identifies neonates with Down syndrome at risk for myeloid leukemia. Leukemia 35 (8) (2021)
David G J Cucchi, Costa Bachas, Marry M van den Heuvel-Eibrink, Susan T C J M Arentsen-Peters, Zinia J Kwidama, Gerrit J Schuurhuis, Yehuda G Assaraf, Valerie de Haas, Gertjan J L Kaspers, Jacqueline Cloos
Harnessing Gene Expression Profiles for the Identification of Ex Vivo Drug Response Genes in Pediatric Acute Myeloid Leukemia. Cancers 12 (5) (2020)